Missouri Patent of the Month – October 2021

Unfortunately, many of us have experienced  the discomfort of a UTI (urinary tract infection). In fact, UTI’s are one of the most common infectious diseases in women. While men do experience them, they are far less common. Women who have experienced a UTI are also far more likely to have a recurring infection. With this high recurrence of UTIs, there is a rapidly growing resistance to antibiotics. As such, Fimbrion Therapeutics, Inc. has been working to develop a new treatment method, focusing on the use of C-mannoside compounds. 

The treatment created by Fimbrion uses C-mannoside compounds which have been found to inhibit FimH. FimH is a bacterial adhesin that helps bacteria such as Escherichia coli to bind to host cells and their receptors. Research has shown that the mannose-binding site FimH adhesin is critical for the colonization and invasion of the bacteria into the bladder epithelium. So stopping this binding should prevent infection from taking hold. The formulation uses mannose-containing small molecules – mannosides – to interfere with the adhesive function of FimH, preventing the bacteria from being able to stick to the walls of the bladder. Ultimately, this allows the body to naturally eliminate the infection on it’s own. Fimbrion is hopeful that this treatment will be able to expand to other bacterial infections while being minimally disruptive to the non-pathogenic, resident beneficial microbiota in your body.. 

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.